Turkey Rx Dry Eye Market is growing at a steady CAGR in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:
Access Full Report at https://www.databridgemarketresearch.com/jp/reports/turkey-rx-dry-eye-market
Turkey Rx dry eye market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to increasing prevalence of dry eye diseases and increasing awareness about diagnosis and treatment of the disease.
The market has witnessed developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative monitoring technology in Rx dry eye market. For instance, In June 2019, Novartis AG completed the acquisition of Xiidra from Takeda Pharmaceutical Company Limited. This strategy would help the company to boost their ophthalmic portfolio in the market.
Novartis AG dominated Turkey Rx dry eye market. The other key players in the market are Bausch & Lomb Incorporated and Allergan, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Alcon Inc., among others.
Novartis AG
Novartis AG is headquartered in Basel, Switzerland which was incorporated in 1996. The company is engaged in the research, development, manufacturing and marketing of healthcare products. The company has wide range of product category such as cancer, cardio-metabolic, immunology & dermatology, neuroscience, ophthalmology and respiratory. The company is continuously engaged in strategic relationship to enhance the product and service of the Rx dry eye market such as,
- In June 2019, Novartis completed the acquisition of Xiidra from Takeda Pharmaceutical Company Limited. This strategy would help the company to boost their ophthalmic portfolio in the market.
The company has presence in Americas, Asia-Pacific, Europe, Middle East and Africa. The company has various Subsidiaries such as Sandoz (Germany), Alcon (U.S.), AveXis (U.S.),Endocyte (U.S.), HexalAG (Germany) among others.
Bausch & Lomb Incorporated
Bausch & Lomb Incorporated is headquartered in New York, U.S. was founded in 1853. The company is focused on offering the widest and finest range of eye health products including contact lenses and lens care products, pharmaceuticals, intraocular lenses and other eye surgery products. The company has wide range of product category such contact lens care, dry eye products, allergy/redness relief, rx pharmaceuticals, eye wash, eye vitamins, surgical products, vision accessories, safety and industrial cleaning products, diagnostics. The company is continuously engaged in strategic relationship to enhance the product and service of the Rx dry eye such as,
- In June 2018, Bausch + Lomb announced the launch of Soothe Xtra Protection (XP) Preservative Free lubricant eye drops by expanding the portfolio of the eye health products for meeting the rising demand for the dry eye symptoms relief without the usage of the preservatives. This will help the company to expand its product portfolio.
The company has presence in North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The company has subsidiary such as ZELTIQ Aesthetics, Inc. (U.S.), Bonti, Inc. (U.S.), Allergan Medical (U.S.), Kythera Biopharmaceuticals, Inc.(U.S.), Oculeve, Inc.(U.S.) among others
Allergan
Allergan is headquartered in Dublin, Ireland was incorporated in 2013. The company is focused on development, manufacturing and commercializing branded pharmaceutical, biologic, device, surgical and regenerative medicine products for patients around the world. The company operates in three business segments which are US Specialized Therapeutics, US General Medicine, International, Other. US Specialized Therapeutics is the market focused segment. The product category of the company includes Medical Aesthetics, Eye Care, Central Nervous System, and Gastroenterology in which Eye Care is the market focused category. The company has 16,900 employees as of December 31, 2018.
- In June 2019, Allergan participated at the Jefferies 2019 Healthcare Conference which was held in New York on 6th June. This would help the company to enhance its customer base.
The company has presence in North America, South America, Europe, Asia-Pacific, Middle East and Africa. The company has subsidiary such as ZELTIQ Aesthetics, Inc. (U.S.), Bonti, Inc. (U.S.), Allergan Medical (U.S.), Kythera Biopharmaceuticals, Inc. (U.S.), Oculeve, Inc. (U.S.) among others.
